Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator.
Verstraete, M
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. [electronic resource] - Lancet (London, England) Apr 1985 - 842-7 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0140-6736
10.1016/s0140-6736(85)92208-1 doi
Adult
Aged
Female
Fibrinogen--analysis
Humans
Male
Middle Aged
Myocardial Infarction--diagnostic imaging
Plasminogen Activators--therapeutic use
Radiography
Streptokinase--therapeutic use
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. [electronic resource] - Lancet (London, England) Apr 1985 - 842-7 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0140-6736
10.1016/s0140-6736(85)92208-1 doi
Adult
Aged
Female
Fibrinogen--analysis
Humans
Male
Middle Aged
Myocardial Infarction--diagnostic imaging
Plasminogen Activators--therapeutic use
Radiography
Streptokinase--therapeutic use